Microbiota in the pathogenesis of COPD and its impact on the course of the disease

Microbiota in the pathogenesis of COPD and its impact on the course of the disease

Chronic obstructive pulmonary disease (COPD) is a serious problem for global health. Infectious agents play a main role in the development of COPD exacerbations. Bacterial colonization of the lower respiratory tract is common in patients with stable COPD. The role of microbiota and host immune respo...

Full description

Bibliographic Details
Main Authors:	Fedotov V.D., Zhestkov A.V., Lyamin A.V., Zaslavskaya M.I., Dobrotina I.S., Tulichev A.A.
Format:	Article
Language:	Russian
Published:	Interregional Association for Clinical Microbiology and Antimicrobial Chemotherapy 2022-09-01
Series:	Клиническая микробиология и антимикробная химиотерапия
Subjects:	microbiota chronic obstructive pulmonary disease pneumococci vaccination
Online Access:	https://cmac-journal.ru/publication/2022/3/cmac-2022-t24-n3-p202/cmac-2022-t24-n3-p202.pdf

Similar Items

Cefodizime: pharmacological characteristics and potential for clinical use in lower respiratory tract infections
by: Rachina S.А., et al.
Published: (2023-09-01)

the effect of 23- valent pneumococcal polysaccharide vaccine on pharyngeal colonization in healthy children under 5 years of age
by: Ahmed M. Rasheed, et al.
Published: (2007-10-01)

Population Pattern of Pneumococci with Lower Susceptibility to Penicillin and Prospects of Antipneumococcal Vaccination to Control Antibiotic Resistance Distribution
by: S. V. Sidorenko, et al.
Published: (2020-05-01)

Molecular epidemiology of piliated pneumococcal isolates at a major tertiary hospital in the Klang Valley, Malaysia
by: Nurul Diana Dzaraly, et al.
Published: (2023-01-01)

Prophylaxis of Community-Acquired Pneumonia Outbreaks with Pneumococcal Polysaccharide Vaccine. Prospects Analysis for Russian Military Community
by: I. A. Guchev, et al.
Published: (2020-05-01)

IMMUNOLOGICAL EFFECT PRODUCED BY VACCINATION WITH «PNEUMO 23» OF CHILDREN WITH CARRIAGE OF STREPTOCOCCUS PNEUMONIA
by: A. L. Sizonenko, et al.
Published: (2014-07-01)

The bactericidal fatty acid mimetic 2CCA-1 selectively targets pneumococcal extracellular polyunsaturated fatty acid metabolism
by: Reithuber, Elisabeth, et al.
Published: (2021)

Anti-bacterial compounds from Indian curry-leaf tree Murraya koenigii have potential to inhibit carbapenem-resistant Streptococcus pneumoniae
by: Soumya Basu, et al.
Published: (2024-07-01)

Molecular architecture of Streptococcus pneumoniae surface thioredoxin‐fold lipoproteins crucial for extracellular oxidative stress resistance and maintenance of virulence
by: Malek Saleh, et al.
Published: (2013-10-01)

Lipoteichoic Acids Are Essential for Pneumococcal Colonization and Membrane Integrity
by: Max Brendel, et al.
Published: (2024-06-01)

Preventive effects of influenza and pneumococcal vaccination in the elderly – results from a population-based retrospective cohort study
by: Norman Rose, et al.
Published: (2021-06-01)

Oxidative stress in COPD, pathogenesis and therapeutic views
by: Fariba Rezaeetalab, et al.
Published: (2014-08-01)

The role of acute and chronic respiratory colonization and infections in the pathogenesis of COPD
by: Leung, Janice M., et al.
Published: (2017)

SEROTYPE CHARACTERISTIC OF PNEUMOCOCCI ISOLATED FROM PATIENTS WITH PNEUMOCOCCAL MENINGITIS
by: I. S. Koroleva, et al.
Published: (2012-07-01)

SMOKING’S ROLE IN THE PATHOGENESIS OF BRONCHIAL AND SYSTEMIC INFLAMMATION AT THE INITIAL STAGE COPD
by: A. E. Shuganov, et al.
Published: (2017-04-01)

A pediatric case series of invasive pneumococcal disease caused by S.Pneumonia serotype-19A despite full dose vaccination
by: Burcu Ceylan Cura Yayla, et al.
Published: (2023-08-01)

CLINICAL PROFILE OF INVASIVE PNEUMOCOCCAL DISEASES AT CHILDREN IN UZBEKISTAN
by: T. A. Daminov, et al.
Published: (2015-09-01)

Etiopathogenetic parallels and unresolved issues of pathogenesis of comorbidity COPD and metabolic syndrome (review)
by: Olga V. Voronkova, et al.
Published: (2020-12-01)

Promising Intestinal Microbiota Associated with Clinical Characteristics of COPD Through Integrated Bioinformatics Analysis
by: Lai T, et al.
Published: (2024-04-01)

Obesity Impact on Dyspnea in COPD Patients
by: Dupuis A, et al.
Published: (2024-07-01)

COPD Pathogenesis and Alterations in the Oral, Lung, and Gut Microbiomes
by: Nobuhiro Asai, et al.
Published: (2024-08-01)

Molecular Epidemiology of Multidrug-Resistant Pneumococci among Ghanaian Children under Five Years Post PCV13 Using MLST
by: Richael O. Mills, et al.
Published: (2022-02-01)

Responsiveness to pulmonary rehabilitation in COPD is associated with changes in microbiota
by: Sara Melo-Dias, et al.
Published: (2023-01-01)

Clinical experience of using double bronchodilation therapy in patients with COPD
by: I. V. Demko, et al.
Published: (2019-12-01)

FEATURES OF THE CLINICAL PICTURE IN SEVERE CHRONIC OBSTRUCTIVE PULMONARY DISEASE
by: M. L. Steiner, et al.
Published: (2014-07-01)

FEATURES OF THE CLINICAL PICTURE IN SEVERE CHRONIC OBSTRUCTIVE PULMONARY DISEASE
by: M. L. Steiner, et al.
Published: (2014-07-01)

The role of «proteolysis-antiproteolysis» system genes in occupational COPD development.
by: A. V. Basanets, et al.
Published: (2018-10-01)

P. gingivalis alters lung microbiota and aggravates disease severity of COPD rats by up-regulating Hsp90α/MLKL
by: Nan Feng, et al.
Published: (2024-12-01)

Comprehensive analysis of the gut microbiota in patients with chronic obstructive pulmonary disease of varying severity-A prospective, observational study
by: Jiali Yan, et al.
Published: (2024-06-01)

Radiation diagnostics of the state of ventilation and pulmonary circulation in patients with COPD
by: O. S. Sementsov, et al.
Published: (2022-03-01)

Performance of COPD population screener questionnaire in COPD screening: a validation study and meta-analysis
by: Yanhui Gu, et al.
Published: (2021-01-01)

THE DYNAMICS OF THE MICROBIOTA OF URINE IN PATIENTS WITH ACUTE OBSTRUCTIVE PYELONEPHRITIS IN PERIODS OF OBSERVATION.
by: Ju. L. Naboka, et al.
Published: (2015-03-01)

Gut–Lung Microbiota Interaction in COPD Patients: A Literature Review
by: Angelika Krumina, et al.
Published: (2022-11-01)

Influence of inflammatory cytokines on the course of chronic obstructive pulmonary disease
by: L.B. Vynnychenko, et al.
Published: (2021-02-01)

EFFECTIVENESS OF PERINDOPRIL AND AMLODIPINE COMBINATION IN HYPERTENSIVES WITH COPD
by: O. N. Kryuchkova, et al.
Published: (2014-11-01)

Inclusion of enterosorbents in anti-inflammatory therapy improve treatment effectiveness in copd patients during exacerbations
by: S. V. Kucher, et al.
Published: (2021-04-01)

ASSESSMENT OF COPD MANAGEMENT COMPLIANCE WITH GOLD 2024 REQUIREMENTS IN POLTAVA REGION
by: V.V. Bilko, et al.
Published: (2024-07-01)

Daily profile and variability of blood pressure in patients with arterial hypertension (AH) in combination with COPD.
by: V. A. Potabashniy, et al.
Published: (2018-05-01)

Understanding COPD-overlap syndromes
by: Poh, Tuang Yeow, et al.
Published: (2017)

Fusobacterium nucleatum: from a classic periodontal pathogen to a complete participant of carcinogenesis
by: Kaiumov K.A., et al.
Published: (2023-03-01)